204 related articles for article (PubMed ID: 35469547)
61. VDR Activation Reduces Proteinuria and High-Glucose-Induced Injury of Kidneys and Podocytes by Regulating Wnt Signaling Pathway.
Guo J; Lu C; Zhang F; Yu H; Zhou M; He M; Wang C; Zhao Z; Liu Z
Cell Physiol Biochem; 2017; 43(1):39-51. PubMed ID: 28848172
[TBL] [Abstract][Full Text] [Related]
62. Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-κB/iNOS signaling in diabetic rat.
Khan S; Jena G; Tikoo K; Kumar V
Biochimie; 2015 Mar; 110():1-16. PubMed ID: 25572918
[TBL] [Abstract][Full Text] [Related]
63. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte.
Jin J; Shi Y; Gong J; Zhao L; Li Y; He Q; Huang H
Stem Cell Res Ther; 2019 Mar; 10(1):95. PubMed ID: 30876481
[TBL] [Abstract][Full Text] [Related]
64. Panax Notoginseng Ameliorates Podocyte EMT by Targeting the Wnt/β-Catenin Signaling Pathway in STZ-Induced Diabetic Rats.
Xie L; Zhai R; Chen T; Gao C; Xue R; Wang N; Wang J; Xu Y; Gui D
Drug Des Devel Ther; 2020; 14():527-538. PubMed ID: 32103895
[TBL] [Abstract][Full Text] [Related]
65. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
[TBL] [Abstract][Full Text] [Related]
66. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
[TBL] [Abstract][Full Text] [Related]
67. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
[TBL] [Abstract][Full Text] [Related]
68. Celastrol antagonizes high glucose-evoked podocyte injury, inflammation and insulin resistance by restoring the HO-1-mediated autophagy pathway.
Zhan X; Yan C; Chen Y; Wei X; Xiao J; Deng L; Yang Y; Qiu P; Chen Q
Mol Immunol; 2018 Dec; 104():61-68. PubMed ID: 30439604
[TBL] [Abstract][Full Text] [Related]
69. Probiotics exert reciprocal effects on autophagy and interleukin-1β expression in
Lai WT; Huang FC
Benef Microbes; 2019 Dec; 10(8):913-922. PubMed ID: 31965835
[TBL] [Abstract][Full Text] [Related]
70. MiR-874 alleviates renal injury and inflammatory response in diabetic nephropathy through targeting toll-like receptor-4.
Yao T; Zha D; Gao P; Shui H; Wu X
J Cell Physiol; 2018 Jan; 234(1):871-879. PubMed ID: 30171701
[TBL] [Abstract][Full Text] [Related]
71. The influence of angiopoietin-like protein 3 on macrophages polarization and its effect on the podocyte EMT in diabetic nephropathy.
Ma Y; Chen Y; Xu H; Du N
Front Immunol; 2023; 14():1228399. PubMed ID: 37638046
[TBL] [Abstract][Full Text] [Related]
72. Liver X receptor activation induces podocyte injury via inhibiting autophagic activity.
Zhang Z; Tang S; Gui W; Lin X; Zheng F; Wu F; Li H
J Physiol Biochem; 2020 May; 76(2):317-328. PubMed ID: 32328877
[TBL] [Abstract][Full Text] [Related]
73. Vitamin D protects podocytes from autoantibodies induced injury in lupus nephritis by reducing aberrant autophagy.
Yu Q; Qiao Y; Liu D; Liu F; Gao C; Duan J; Liang L; Di X; Yuan Y; Gao Y; Cui S; Qin Y; Li T; Zheng Z; Liu Z
Arthritis Res Ther; 2019 Jan; 21(1):19. PubMed ID: 30635032
[TBL] [Abstract][Full Text] [Related]
74. [Protective effects of Shenkangwan against podocyte injury in rats with early diabetic nephropathy].
Long HB; Zhang H; Zhong J; Zhu Y; He JH; Wei LB
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1268-72. PubMed ID: 18676280
[TBL] [Abstract][Full Text] [Related]
75. Mutation of Beclin1 acetylation site at K414 alleviates high glucose-induced podocyte impairment in the early stage of diabetic nephropathy by inhibiting hyperactivated autophagy.
Xu J; Deng Y; Ke Y; Zhu Y; Wang P; Yu Q; Li C; Shi B
Mol Biol Rep; 2022 May; 49(5):3919-3926. PubMed ID: 35175505
[TBL] [Abstract][Full Text] [Related]
76. Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis.
Lenoir O; Jasiek M; Hénique C; Guyonnet L; Hartleben B; Bork T; Chipont A; Flosseau K; Bensaada I; Schmitt A; Massé JM; Souyri M; Huber TB; Tharaux PL
Autophagy; 2015; 11(7):1130-45. PubMed ID: 26039325
[TBL] [Abstract][Full Text] [Related]
77. Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway.
Huang G; Lv J; Li T; Huai G; Li X; Xiang S; Wang L; Qin Z; Pang J; Zou B; Wang Y
Int J Mol Med; 2016 Oct; 38(4):1179-89. PubMed ID: 27571993
[TBL] [Abstract][Full Text] [Related]
78. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
[TBL] [Abstract][Full Text] [Related]
79. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
80. Autophagy is involved in regulating VEGF during high-glucose-induced podocyte injury.
Miaomiao W; Chunhua L; Xiaochen Z; Xiaoniao C; Hongli L; Zhuo Y
Mol Biosyst; 2016 Jun; 12(7):2202-12. PubMed ID: 27138352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]